Spitomin tablets 10mg, No. 60
Expiration Date: 05/2027
Russian Pharmacy name:
Спитомин таблетки 10мг, №60
generalized anxiety disorder (GAD);
panic disorder;
autonomic dysfunction syndrome;
alcohol withdrawal syndrome (as adjuvant therapy);
depressive disorders - adjuvant therapy (the drug is not prescribed for depression monotherapy).
Inside, always at the same time of the day, before or after meals (to avoid significant fluctuations in the concentration of the active substance in the blood plasma throughout the day).
The drug should not be taken sporadically for the treatment of anxiety, since the therapeutic effect of SpitominЃ develops only after repeated administration and does not appear earlier than after 7-14 days of treatment.
The dose should be selected for each patient individually. The recommended starting dose is 15 mg; it can be increased by 5 mg / day every 2 or 3 days. The daily dose should be divided into 2-3 doses. The usual daily dose is 20-30 mg. The maximum single dose is 30 mg; the maximum daily dose should not exceed 60 mg.
Special patient groups
Elderly patients. By itself, old age does not require dose adjustment, since the pharmacokinetics of buspirone does not undergo age-related changes.
Impaired renal function. In case of impaired renal function, the drug should be used with caution and in reduced doses.
Liver dysfunction. In case of impaired liver function, the drug should be used with caution and in reduced doses, for which individual doses are reduced or the interval between doses is increased.
| Pills | 1 tab. |
| active substance: | |
| buspirone hydrochloride | 5 mg |
| 10 mg | |
| excipients: lactose monohydrate - 55.7 / 111.4 mg; MCC; sodium carboxymethyl starch; magnesium stearate; anhydrous colloidal silicon dioxide |
hypersensitivity to any component of the drug;
severe renal failure (glomerular filtration rate (GFR) is below 10 ml / min);
severe hepatic impairment (PV - more than 18 s);
simultaneous use of MAO inhibitors or a 14-day period after the cancellation of an irreversible MAO inhibitor, or 1 day after the cancellation of a reversible MAO inhibitor;
glaucoma;
myasthenia gravis;
lactation;
pregnancy or suspected pregnancy;
age up to 18 years (the safety and effectiveness of buspirone for this age group has not been proven).
With care: cirrhosis of the liver, renal failure (see 'Special instructions').